Moreover, activation of IL-1β in AD is linked to the NLRP3 inflammasome [96], and we have reported NLRP3 inflammasome formation and IL-1β activation in visceral adipose tissue and pancreas [44], known intermediaries of metabolic diseases. Here, NLRP3 is linked to Other metabolic disease.